about
Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomesThe opioid effects of gluten exorphins: asymptomatic celiac diseaseDipeptidyl peptidase-4 inhibitors: multitarget drugs, not only antidiabetes drugs.Angioedema with normal laboratory values: the next step.The pharmacokinetic considerations and adverse effects of DPP-4 inhibitors [corrected].DPP-4 inhibitors: a patent review (2012 - 2014).Management and treatment of chronic urticaria (CU).
P2860
Q26785454-B4B6E643-75FA-4818-AABD-0FAAAA3CBD24Q28077385-523C4E20-D67D-4EBC-98FF-597A22C46C63Q38107546-FF3219D3-083D-47D0-A841-B13A7774E34EQ38131740-D101A2DE-E94B-41A5-A263-CE0D769C982AQ38205588-7CC35096-DF02-4800-A31B-9B6D3BD9EC05Q38284522-E2F32479-F7B9-4C8F-ABF7-4C56EFD4D8B7Q52938044-082A8F76-D1D1-4F77-BA4F-6D1F90067778
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Sitagliptin-associated angioedema.
@en
Sitagliptin-associated angioedema.
@nl
type
label
Sitagliptin-associated angioedema.
@en
Sitagliptin-associated angioedema.
@nl
prefLabel
Sitagliptin-associated angioedema.
@en
Sitagliptin-associated angioedema.
@nl
P2860
P356
P1433
P1476
Sitagliptin-associated angioedema.
@en
P2093
Aidar R Gosmanov
Eric C Fontenot
P2860
P356
10.2337/DC12-0574
P407
P577
2012-08-01T00:00:00Z